Company: OMQS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023481
Chunk: 15

Company: OMNIQ Corp.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 15
---
 was $0.09 versus loss of ($0.46) per share for the same period in 2024.

LIQUIDITY
AND CAPITAL RESOURCES

As of September 30, 2025, the Company had cash in the amount of $679 thousand
and a working capital deficit of $11.8 million, compared to cash in the amount of $2.3 million, and a working capital deficit of $54 million
as of December 31, 2024. The Company had stockholders’ deficit attributable to OmniQ stockholders of $13 million and $43.9 million
as of September 30, 2025, and December 31, 2024, respectively. This decrease in our stockholders’ deficit was primarily attributable
to the sale of one of the divisions at June 30, 2025.

The Company’s accumulated deficit was $124.7
million and $123.9 million as of September 30, 2025, and December 31, 2024.

The Company’s operations provided net cash of $5.4 million and
provided $230 thousand in the nine months ended September 30, 2025, and 2024, respectively. The increase in cash used by operations of $5.2
million is due to an increase in accounts receivables being received as well as reliance on accounts payable being accrued.

The
Company’s cash used in investing activities was $2.5 million for the nine months ended September 30, 2025, compared to cash
used by investing activities of $87 thousand for the nine months ended September 30, 2024.

The Company’s financing activities
used $2 million of cash during the nine months ended September 30, 2025, and used $2.4 million during the nine months ended
September 30, 2024. During the nine months ended September 30, 2025, the Company made payments of $3.4 million on its notes
payable, compared to the payments of $2.7 million for the nine months ended September 30, 2024.

4

Results
of Operations

The
following tables set forth certain selected unaudited condensed consolidated statement of operations data for the periods indicated in
dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

    Three months ended September 30,  
    Variation 
  
    In thousands 
    202